UBS Group AG - LIXTE BIOTECHNOLOGY HLDGS IN ownership

LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXTW and the CUSIP is 539319111. A total of 6 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LIXTE BIOTECHNOLOGY HLDGS IN
ValueSharesWeighting
Q1 2023$70811
-89.4%
0.00%
Q3 2022$0
-100.0%
7,623
+1.2%
0.00%
Q2 2022$1,000
-50.0%
7,533
-12.4%
0.00%
Q1 2022$2,000
-33.3%
8,600
+37.6%
0.00%
Q4 2021$3,000
-40.0%
6,250
-26.7%
0.00%
Q3 2021$5,000
-28.6%
8,524
-5.6%
0.00%
Q2 2021$7,000
+16.7%
9,034
+25.8%
0.00%
Q1 2021$6,000
-71.4%
7,179
-69.1%
0.00%
Q4 2020$21,00023,2400.00%
Other shareholders
LIXTE BIOTECHNOLOGY HLDGS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Empery Asset Management, LP 99,835$12,0000.06%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 32,284$4,0000.00%
CLEAR STREET LLC 85,211$10,0000.00%
Warberg Asset Management LLC 12,000$2,0000.00%
UBS Group AG 7,533$1,0000.00%
View complete list of LIXTE BIOTECHNOLOGY HLDGS IN shareholders